Studies have shown gelatin methacrylate (GelMA) as a bioactive hydrogel with diverse tissue growth applications.
Research on developing functional polymeric scaffolds has been conducted in diverse tissue engineering applications for a few decades.
A common feature of tumors arising from diverse tissue types is a reliance on aerobic glycolysis for glucose metabolism.
Poly(ε-caprolactone) triacrylate (PCLTA) developed in our laboratory is a photo-crosslinkable, injectable, and biodegradable polymeric biomaterial for diverse tissue engineering applications.
Animal skeletons have been designed through optimization by natural selection to physically support and physiologically maintain diverse tissue types encompassing a variety of functions.
Our results suggest that these polymers are potentially useful as injectable, self-crosslinkable, and photo-crosslinkable materials for diverse tissue engineering applications.
Here, we report the successful adaptation of this method for generating complex tissues from diverse tissue fragments derived from various organs, including pancreatic islets.
A number of biodegradable and bioresorbable materials, as well as scaffold designs, have been experimentally and/or clinically studied for tissue engineering of diverse tissue types.
Additionally, diverse tissue response cascades following disease/injury in the CNS add more challenges to regeneration such as increased inflammation, invading cells, and glial scarring.
This review is focused on recent developments in the isolation of novel AAV serotypes and isolates, their production and purification, diverse tissue tropisms, mechanisms of cellular entry/trafficking, and capsid structure.
This novel strategy for vaccine design not only enables enhanced immunity to a universal tumor antigen, but also has the potential to generate CTLs effective in telomerase-positive tumor cells of diverse tissue origins.
